FDA Releases Guidance for Industry on Dear Health Care Provider Letters

Summary

The Food and Drug Administration (FDA) has finalized a guidance document outlining recommendations for industry on the content and format of Dear Health Care Provider (DHCP) letters, which are used to communicate important safety information to healthcare providers.